0000905729-17-000293.txt : 20171106 0000905729-17-000293.hdr.sgml : 20171106 20171106142950 ACCESSION NUMBER: 0000905729-17-000293 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171030 FILED AS OF DATE: 20171106 DATE AS OF CHANGE: 20171106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WENDT KATHLEEN S. CENTRAL INDEX KEY: 0001598913 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-08185 FILM NUMBER: 171179159 MAIL ADDRESS: STREET 1: 235 E. MAIN STREET CITY: MIDLAND STATE: MI ZIP: 48640 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMICAL FINANCIAL CORP CENTRAL INDEX KEY: 0000019612 STANDARD INDUSTRIAL CLASSIFICATION: STATE COMMERCIAL BANKS [6022] IRS NUMBER: 382022454 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E MAIN ST CITY: MIDLAND STATE: MI ZIP: 48640 BUSINESS PHONE: 989-839-5350 MAIL ADDRESS: STREET 1: 235 E MAIN ST CITY: MIDLAND STATE: MI ZIP: 48640 3 1 wendt3_110617.xml OWNERSHIP DOCUMENT X0206 3 2017-10-30 0 0000019612 CHEMICAL FINANCIAL CORP CHFC 0001598913 WENDT KATHLEEN S. 235 E. MAIN STREET MIDLAND MI 48640 0 0 0 1 Officer of Principal Bus. Unit Common Stock 0 D /s/ Lori A. Gwizdala, Her Attorney-In-Fact 2017-11-06 EX-24 2 wendtpoa.htm LIMITED POWER OF ATTORNEY

EXHIBIT 24

LIMITED POWER OF ATTORNEY

The undersigned, a director and/or officer of Chemical Financial Corporation, a Michigan corporation (the “Company”), does hereby appoint THOMAS C. SHAFER, DENNIS L. KLAESER, WILLIAM C. COLLINS, LORI A. GWIZDALA, JEFFREY A. OTT, and G. CHARLES GOODE, or any one or more of them, with full power of substitution, his or her attorneys and agents to do any and all acts and things and to execute and file any and all documents and instruments that such attorneys and agents, or any of them, consider necessary or advisable to enable the undersigned (in his or her individual capacity or in a fiduciary or other capacity) to comply with the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and any requirements of the Securities and Exchange Commission in respect thereof, in connection with his or her intended sale of any security related to the Company pursuant to Rule 144 issued under the Securities Act and the preparation, execution and filing of any report or statement of beneficial ownership or changes in beneficial ownership of securities of the Company that the undersigned (in his or her individual capacity or in a fiduciary or other capacity) may be required to file pursuant to Section 16(a) of the Exchange Act including, without limitation, full power and authority to sign the undersigned’s name, in his or her individual capacity or in a fiduciary or other capacity, to any report or statement on Form 3, 4, 5 or 144, or to any amendments or any successor forms thereto, or any form or forms adopted by the Securities and Exchange Commission in lieu thereof or in addition thereto, hereby ratifying and confirming all that such attorneys and agents, or any of them, shall do or cause to be done by virtue hereof.

The undersigned agrees that the attorneys-in-fact named herein may rely entirely on information furnished orally or in writing by the undersigned to such attorneys-in-fact.

This authorization shall supersede all prior authorizations to act for the undersigned with respect to securities of the Company in these matters, which prior authorizations are hereby revoked, and shall survive the termination of the undersigned’s status as a director and/or officer of the Company and remain in effect thereafter for so long as the undersigned (in his or her individual capacity or in a fiduciary or other capacity) is subject to Rule 144 with respect to securities of the Company or has any obligation under Section 16 of the Exchange Act with respect to securities of the Company.

Date: November 3, 2017	/s/ Kathleen S. Wendt
	(Signature)

	Kathleen S. Wendt
	(Print Name)